Navigation Links
Bayer Temporarily Suspends Global Trasylol(R) Marketing
Date:11/5/2007

LEVERKUSEN, Germany and WEST HAVEN, Conn., Nov. 5 /PRNewswire/ -- Following consultation with the German Federal Institute for Drugs and Medical Devices (BfArM), the U.S. Food and Drug Administration (FDA), Health Canada, and other health authorities, Bayer announced today that it has elected to temporarily suspend worldwide marketing of Trasylol(R) (aprotinin injection) until final results from the Canadian BART trial can be compiled, received and evaluated. The company took this global action following direction from the German BfArM and requests from the FDA and other regulators that Bayer temporarily suspend Trasylol marketing in their respective countries until final BART data were available. The BART study is an independent randomized, controlled trial being conducted in high-risk cardiac surgery patients.

Once the complete BART dataset is available, Bayer will work with health authorities to evaluate whether these data have any impact on the positive benefit-risk assessment for Trasylol. At that time the temporary marketing suspension will be reevaluated. Additionally, the U.S. FDA, Health Canada and other health authorities have indicated their interest in working with Bayer to create a program for use during the temporary suspension under which physicians in these markets might request and receive Trasylol for treatment of certain surgical patients with an established medical need. Bayer will work with the FDA, Health Canada, and any other authorities who wish to institute similar programs, to outline appropriate patient profiles and the specific details.

This action follows notification to Bayer and regulatory authorities that the BART Executive Committee had halted the trial after a planned periodic data analysis indicated reduced bleeding but also an increase in all-cause mortality (that almost reached conventional statistical significance for 30- day mortality) for patients in the aprotinin treatment arm compared to patients who recei
'/>"/>

SOURCE Bayer HealthCare
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
2. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
3. Bayer HealthCare Cleared to Acquire Citracal(R)
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
6. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
7. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
8. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
9. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
10. Briefing on a new Web resource to address global drinking water crisis
11. MDS Pharma Services Wins Award for Management of Global Malaria Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... (PRWEB) November 28, 2014 This is ... of the global Bronchoscopes industry with a focus on ... the market status of the Bronchoscopes manufacturers and is ... and individuals interested in the industry. , Firstly, the ... its definition, applications and manufacturing technology. Then, the report ...
(Date:11/27/2014)... The American Society for Clinical Pathology (ASCP) ... in honor of World AIDS Day 2014. On Nov. 25, ... cure.” icon and infographic designed to generate public awareness about ... HIV. , ASCP has asked members to replace their Facebook, ... Get Tested. Find a cure.” icon and share the accompanying ...
(Date:11/27/2014)... 27, 2014 According to a recent ... looking to break into the surgical robotics market ... other than the MIS field dominated by Intuitive. These ... U.S. surgical robotics market by 2020. , “The ... Kamran Zamanian, CEO and President of iData. “System sales ...
(Date:11/27/2014)... November 27, 2014 In a ... allot to sleep has lessened, and due to ... the quality of sleep has eroded. According to ... on the job (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). This ... index by an incalculable amount, leading not only ...
(Date:11/27/2014)... PITTSBURGH, PA (PRWEB) November 27, 2014 ... suffer the embarrassing side effects of urinary incontinence," said ... to it and developed this specialized accessory to prevent ... developed the Incontinence to absorb urine leakage. This prevents ... wearer from potential embarrassment. The pad ensures that the ...
Breaking Medicine News(10 mins):Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 3Health News:ASCP Launches Social Media Campaign in Honor of World AIDS Day 2Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2
... 21 Omnicell,Inc. (Nasdaq: OMCL ), a leading ... results for its first quarter ended,March 31, 2008., ... totaled $62.1,million, up $4.1 million or 7.2% from the ... from the first quarter of 2007., First quarter ...
... MDS Board, TORONTO, April 21 /PRNewswire-FirstCall/ - MDS ... and services to the global life,sciences markets, today announced ... William Dempsey, former Executive Vice-President,of Abbott Laboratories, have been ... both Greg and Bill and look forward to benefiting ...
... 6 millimeters in diameter appear more likely to be ... the April issue of Archives of Dermatology, one of ... guidelines currently used by dermatologists to screen for melanoma ... to screen for melanoma, according to background information in ...
... Insurance,Holdings, Inc. ("EIHI") (Nasdaq: EIHI ) today ... (Excellent) financial strength ratings of EIHI members,Eastern Alliance ... Company ("ELH") and upgraded the outlook for EAIG ... specializing in workers,compensation. A.M. Best reaffirmed a stable ...
... also finds survival rates similar, no matter when admission ... to heart attack patients who arrive at hospitals during ... hours tend to receive faster and more comprehensive care, ... affect in-hospital death rates of heart attack patients, said ...
... Successful Transition, BIRMINGHAM, Ala., April 21 ... Hayek has been named president and,chief executive officer ... executive officer, Mike Snow, is resigning his position ... as an advisor on the company,s,board of directors., ...
Cached Medicine News:Health News:Omnicell Announces First Quarter 2008 Results 2Health News:Omnicell Announces First Quarter 2008 Results 3Health News:Omnicell Announces First Quarter 2008 Results 4Health News:Omnicell Announces First Quarter 2008 Results 5Health News:Omnicell Announces First Quarter 2008 Results 6Health News:Omnicell Announces First Quarter 2008 Results 7Health News:Omnicell Announces First Quarter 2008 Results 8Health News:Omnicell Announces First Quarter 2008 Results 9Health News:Omnicell Announces First Quarter 2008 Results 10Health News:Omnicell Announces First Quarter 2008 Results 11Health News:MDS Appoints Two New Directors 2Health News:MDS Appoints Two New Directors 3Health News:Larger skin lesions appear more likely to be melanomas 2Health News:Eastern Alliance Insurance Group and Eastern Life and Health Insurance Company Announce Affirmation of A- (Excellent) A.M. Best Ratings and a Positive Outlook for Eastern Alliance Insurance Group 2Health News:Eastern Alliance Insurance Group and Eastern Life and Health Insurance Company Announce Affirmation of A- (Excellent) A.M. Best Ratings and a Positive Outlook for Eastern Alliance Insurance Group 3Health News:Off-Hours Heart Patients Less Likely to Get Angioplasty 2Health News:SCA Names Andrew Hayek as New President and CEO 2
(Date:11/26/2014)... , Nov. 26, 2014  BioScrip ® , Inc. (NASDAQ: ... , President and Chief Executive Officer, will present at the Bank ... , , , Date: , , , Wednesday, December ... 2:50 p.m. EST , , , , Location: , , ... About BioScrip, Inc. BioScrip, Inc. ...
(Date:11/26/2014)... RADNOR, Pa. , Nov. 26, 2014 ... dedicated to the development of innovative transdermal synthetic cannabinoid ... the Piper Jaffray 26th Annual Healthcare Conference 2014. The ... the New York Palace in New York ... , will present at 4:50 pm on Tuesday, December ...
(Date:11/26/2014)... , Nov. 26, 2014  Aridis Pharmaceuticals, ... produce novel therapies for infectious diseases, announced today ... an internationally recognized key opinion leader in the ... scientific advisory board. Founder and Chief ... "We believe Dr. Opal,s extensive experience investigating bacterial ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3
... A new study by researchers at Harvard ... vitamins, including B6, B12, and folic acid, lower risk ... leading causes of vision loss among older Americans. These ... fatty acids and phytosterols, are also contained in the ...
... and PCPs Vary in Their Prescribing Patterns of Levodopa/Carbidopa ... Decision ResourcesWALTHAM, Mass., March 4 Decision Resources, one ... on pharmaceutical and healthcare issues, finds that second-line patient ... 14.1 percent to 35.2 percent since last year,s report. ...
Cached Medicine Technology:Harvard Study Shows Folic Acid, B Vitamins in Animi-3(R) May Prevent Vision Loss 2Teva's Azilect Use Dramatically Increases in Second-Line Therapy for the Treatment of Parkinson's Disease 2Teva's Azilect Use Dramatically Increases in Second-Line Therapy for the Treatment of Parkinson's Disease 3
Used for endobronchial blockade of the left or right lung for procedures which require one-lung ventilation. Supplied sterile in peel-open packages. Intended for one-time use....
... can establish an airway (up to 7.2 mm ... used for fast and safe emergency airway access., ... and a 7.2 mm I.D. airway within seconds. ... ventilation. A suction catheter can be introduced through ...
... Howland lock handle - Chrome-plated brass. Rusch ... standard laryngoscope handles that are compatible with ... standards. The designs of these handles have ... use the world over to minimize maintenance ...
... Standard Chrome plated brass. Available ... a reliable tradition of high quality ... with all standard/conventional blades manufactured to ... these handles have been continually refined ...
Medicine Products: